|
Advanced Polymers for Medical Applications: Materials, Product Development, and Market Opportunities Abstract In virtually all areas of medicine, increasingly sophisticated devices are turning to increasingly sophisticated materials science to solve their most nagging technical problems. From passive functions like sterility and biocompatibility to active drug delivery and even conductivity, polymers are proving to be more versatile and complex than ever before. Kalorama's Advanced Polymers for Medical Applications examines the latest technological and market developments in advanced plastics for:
Patent applications and clinical trial information combined with commercial, regulatory, and manufacturing issues will present a comprehensive picture of these quickly evolving technologies and their promising and dynamic marketplace.
Table of Contents Chapter One: Introduction to Polymers for Medical Applications
Some Fundamental Concepts Properties of Polymers Synthesis Physical Properties of Solid Polymers Mechanical Properties Thermal Properties Classes of Polymers Used in Medicine Medical Polymers Come of Age Legislation can Reduce the Risks of Innovation Merging Polymer Science and Biology Exciting Research: Biopolymer Optics and Electronics Synthesizing Active Polymers with Potential Bio-Interfaces Chapter Two: Biodegradable Polymers and Medical Applications
Biocompatibility Biodegradable Polymers Medical Applications of Biodegradable Polymers Hydrogels Currently Available Degradable Polymers Chapter Three: Bone and Cartilage Replacement
Bone Morphogenic Proteins Starting the Bone Growth Process Tissue Engineers Build New Bone Gene Therapy New Stem Cell Sources Artery/Cartilage Replacement Biomaterial Production of Human-Like Finger Joint Protein Delivery System May Help Fight Osteoporosis Inorganic Materials and Enzymes Disperse into Biodegradable Composites Cell-Loaded Matrix Can Repair Bones Chapter Four: Dressings for Burns and Chronic Wounds
Bioreactive Fabrics Chapter Five: Molecular Imprinted Polymers
Process Overview History Making an Imprint Advantages and Limitations Examples of Molecular Imprinted Polymers Future Directions Pros and Cons Plastics with Molecular Memory Chemical Sensors Molecular Imprinted Polymers for Chromatographic Separation Preparation and Optimization Cutting Edge Research and the Future Chapter Six: Polymer Coatings and Surfaces for Medical Applications
Polymer Coatings for Medical Products Polymer Coatings and Substrates for Drug Delivery Applications Coating Process May Prevent Body from Rejecting Medical Implants Surfaces Provide Key to Design of Clinically Useful Materials Chapter Seven: Tissue Engineering
Overview An Emerging Industry Factors Driving Tissue Engineering Development Dog Bladders and Human Hearts Mass-Producing Polymer Scaffolds Cell Culture in Three Dimensions Animal Rights Preserving and Shipping Artificial Tissues and Organs Photopolymers Chapter Eight: Product Development, Approval, and Regulations
Overview Historical Overview of Medical Materials and Device Regulation The Review and Approval Processes: Step by Step Device Testing Factors in Biocompatibility Evaluations Who Writes Standards? Who Uses Standards? The American Society For Testing and Materials System Committees Chapter Nine: Market Perspective
The Healthcare Marketplace The Evolution of Medical Polymers Tissue Engineering: Spare Parts Medical Coatings Market Segment Diagnostic Testing Segment Biomaterials Barriers to Progress Chapter Ten: Company Profiles ABIOMED, Inc. Acordis BV Alexion Pharmaceuticals, Inc. Allergan, Inc. Alza Corporation (Johnson & Johnson) Apogent Technologies Inc. Arrow International, Inc. Ballard Medical Products (Kimberly-Clark Health Care) C. R. Bard, Inc. Bausch & Lomb Inc. Baxter International Inc. Becton, Dickinson and Co. Biocompatibles International Plc Biomet, Inc. Bionx Implants, Inc. Boston Scientific Corporation Carrington Laboratories, Inc. Ciba Specialty Chemicals Holding Inc. Clontech Laboratories, Inc. ConvaTec CryoLife, Inc. Curative Health Services, Inc. DePuy Inc. Guidant Corporation Haemonetics Corporation Imagyn Medical Technologies, Inc. Imperial Chemical Industries Plc Implant Sciences Corporation INAMED Corporation Integra LifeSciences Holdings Corporation Interpore International, Inc. LifeCell Corporation Medtronic Sofamor Danek, Inc. Mentor Corporation Nobel Biocare AB Organogenesis Inc. Ortec International, Inc. Orthofix International N.V. OrthoLogic Corp. Osteotech, Inc. Planet Polymer Technologies, Inc. Polymer Group, Inc. ProCyte Corporation Protein Polymer Technologies, Inc. Smith & Nephew Plc Stryker Corporation Sulzer Medica Ltd Synthetech, Inc. Tutogen Medical Inc. Wright Medical Group, Inc. Zimmer Holdings, Inc. Appendix A: Standard Terminology for Abbreviated Terms Relating to Plastics ASTM D 1600-92 Appendix B: Plaspec Materials Selection Database
More Details Innovation in Cell Hosting, Drug Delivery, and Biocoatings Drive Advanced Medical Polymers into New Era New York, February 5, 2002 /PR Newswire — Advanced polymer research is leading to thousands of new and innovative medical devices, many of which were not possible only a few years ago, according to a new study released today by Kalorama Information and available at MarketResearch.com. Those areas with the most potential appear to be applications in tissue engineering and transplant medicine, devices that deliver pharmaceuticals, and specialized polymer coatings that allow for more complex device design, according to the study. The study, Advanced Polymers for Medical Applications, found a plethora of opportunity in new polymer research, noting that the markets for some applications such as cell hosting in which a polymer scaffold makes tissue growth possible, have nearly unlimited growth potential. The market potential for tissue-engineered healthcare solutions has been estimated at over $80 billion, according to the study. Some other areas of promising research identified by the study include biodegradable polymers and hydrogels, molecular imprinted polymers, conductive polymers, and biopolymers. "A few years ago medical device designers were forced to work with a small handful of classic biomaterials, and polymers were used in medical implants only as inert structural materials," notes James P. Smith, PhD, the author of the report. "However, the standard concept of a medical implant as an inanimate, mechanical product seldom applies today. Advanced medical polymers are now capable of biological processes, and can become a functional part of living organisms." The study also found, though, that there are significant obstacles to progress in the sector. Nuances of medical device regulation and the unique structure of the healthcare markets have created barriers to product development, especially for companies that are entering the medical arena for the first time. The report contains an extensive step-by-step review of the approval process and the industry’s standards.
About Kalorama Information
About MarketResearch.com
Buy by the Section
|